From Watchdog to Ally: Merlino Takes the Helm at The Joint Commission

OAKBROOK TERRACE, Illinois – September 23, 2026 – Following a transformative half-decade that fundamentally rewired the relationship between American hospitals and their chief regulator, Jonathan B. Perlin, MD, PhD, announced his retirement as president and CEO of The Joint Commission, effective December 31, 2026. The organization’s Board of Commissioners has appointed Dr. James I. Merlino, the current chief operating officer, to assume the top post on January 1, 2027.

The handover represents a meticulously orchestrated succession at the nation’s oldest and largest healthcare accrediting body, an enterprise that evaluates more than 23,000 facilities nationwide. Under Dr. Perlin’s five-year stewardship, the nonprofit pivoted sharply from a punitive compliance enforcer into a collaborative, data-driven partner. Now, as the healthcare industry faces an era defined by razor-thin margins and intense regulatory scrutiny, Dr. Merlino is tasked with proving that reducing administrative burdens can actively elevate patient safety.

"Jon’s legacy is one of service, trust, and commitment," said Michael Suk, MD, chairman of the Board of Commissioners. "His absolute dedication to supporting the noble work of our nation’s healthcare systems in elevating safety and quality – from the smallest rural hospital to the largest, most complex urban health system – is his life’s work. It’s been inspiring to see the impact he has made through his leadership."

Dismantling the Bureaucratic Watchdog

For decades, hospital administrators viewed accreditation surveys as high-stakes, episodic interrogations. The process was widely criticized for prioritizing paperwork over patient outcomes, generating a checklist reflex that did little to improve actual clinical reliability.

When Dr. Perlin took the helm in 2022, he initiated the most aggressive de-implementation of obsolete standards since the inception of Medicare in 1965. The culmination of this effort, dubbed Accreditation 360, effectively slashed hospital standing requirements by 50 percent—reducing the manual from 1,551 to 774 essential standards. The accreditor targeted rules that were redundant with federal statutes, rarely scored, or simply disproportionate in their operational burden compared to their clinical benefit.

"It’s been an extraordinary privilege to serve the mission of advancing healthcare safety as organizations are navigating what is undeniably the most complex, formidable landscape in history," said Dr. Perlin. "I’ve dedicated my life to improving quality and safety for patients, and it’s been my absolute honor to work alongside so many who share the same mission."

Beyond trimming the fat, the enterprise fundamentally altered its survey philosophy. It retired the purely fault-finding "Safety 1.0" model in favor of a "Safety 2.0" framework. This new system catalogs institutional strengths and builds a national repository of validated, high-reliability clinical workflows.

The industry’s response has been overwhelmingly positive. As the chief executive of one major midwestern health system noted recently, the new framework provides the timely, practical support that aligns with modern care delivery, replacing a punitive approach with a collaborative, outcomes-focused model.

The Patient Experience Pioneer

The selection of Dr. Merlino as the eighth president and CEO signals a doubling down on this collaborative ethos. A practicing colorectal surgeon, Dr. Merlino brings three decades of executive experience, most notably steering large-scale cultural transformations at the Cleveland Clinic and Press Ganey.

"The Board chose Jim because of his focus on the patient and his international reputation," said Eric Langshur, vice-chairman of the Board of Commissioners. "He has a proven operational track record, and an ability to identify opportunities and quickly build and innovate. Jim also possesses an international lens and perspective in terms of growing our ability to support healthcare organizations across the world."

During his tenure as chief experience officer at the Cleveland Clinic, Dr. Merlino pioneered the concept that patient experience is inextricably linked to clinical excellence. He successfully shifted the institution from lagging satisfaction rankings into the top national deciles by aligning caregiver communication, empathy, and the physical environment under a unified cultural banner. Later, as chief transformation officer at Press Ganey, he advised dozens of health system boards on the indivisible nature of patient safety and workforce culture.

Since joining the accreditor as chief innovation officer in August 2023, and subsequently stepping into the COO role, Dr. Merlino has been the co-architect of the organization's recent modernization.

"Jon is a long-time colleague and friend. He has charted a course for Joint Commission that has revolutionized the way we look at safety and quality in our healthcare systems," said Dr. Merlino. "I’m deeply grateful for the opportunity to meaningfully carry forward that plan, while simultaneously advancing the next chapter of innovation and strategic improvement... We are at a critical moment in healthcare. Healthcare quality and patient safety have never been more important. Safe, high-quality, patient-centered care should not be a burden. It is our responsibility."

Navigating Regulatory Headwinds and Global Expansion

Dr. Merlino assumes command at a time of escalating external pressures. In June 2026, the Centers for Medicare & Medicaid Services (CMS) finalized stringent new oversight rules for private accreditors. The regulations introduced strict conflict-of-interest firewalls, mandated real-time direct-observation validation surveys, and required public remediation plans for disparity rates between state and private inspections.

Simultaneously, the organization faces stiff competition from agile rivals utilizing ISO 9001 Quality Management Systems, who have gained market share by promising highly predictable, process-oriented annual surveys. The recent rollout of continuous data feeds and real-time performance check-ins is a direct strategic maneuver to neutralize this competitive threat, proving that the legacy accreditor can be just as dynamic and customer-centric.

While defending its domestic flank, the enterprise is also rapidly expanding its global footprint. Dr. Perlin championed the Patient Safety Pathways Program, a targeted initiative deployed across 30 low- and middle-income countries. Recognizing that in resource-limited settings a significant portion of healthcare encounters result in preventable harm, the program bypasses capital-intensive infrastructure requirements in favor of scalable clinical capabilities—such as diagnostic verification, hand hygiene compliance, and surgical safety checklists.

To ensure continuity in these vital global efforts, the Board has asked Dr. Perlin to remain engaged as a strategic advisor and president emeritus. In this capacity, he will safeguard international relationships and oversee the continued expansion of the global safety network.

A Blueprint for Institutional Resilience

In an era where executive turnover in healthcare frequently triggers strategic whiplash, this leadership handoff stands out for its deliberate orchestration. By elevating a deeply aligned internal operator to the chief executive role, the Board of Commissioners has guaranteed that the massive structural reforms initiated over the past five years will not be abandoned.

For the 23,000 facilities relying on the organization's seal of approval, the message is one of stabilizing continuity. The shift from a bureaucratic watchdog to a strategic ally is not a temporary pandemic-era concession, but the permanent new baseline for healthcare regulation. As hospitals continue to navigate workforce shortages and financial headwinds, they will do so with an accreditor that finally views safety as a shared operational pursuit rather than a standardized test.